Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.670
+0.070 (4.37%)
At close: Mar 9, 2026, 4:00 PM EDT
1.600
-0.070 (-4.19%)
After-hours: Mar 9, 2026, 6:07 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $13.34 million as of March 9, 2026. Its market cap has decreased by -22.06% in one year.
Market Cap
13.34M
Enterprise Value
6.37M
1-Year Change
-22.06%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $13.34M, a decrease of -96.74%. That is a compound annual growth rate of -23.75%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curis | 13.56M |
| Jupiter Neurosciences | 13.32M |
| OSR Holdings | 13.18M |
| Kairos Pharma | 13.12M |
| BioLineRx | 12.68M |
| NewcelX | 12.63M |
| BioCardia | 12.52M |
| Phio Pharmaceuticals | 12.49M |